SLC12A2 and Alzheimer disease: Rapamycin, an mTORC1 inhibitor, restores NKCC1/KCC2 balance and reduces seizure pathology, whereas the contribution of the WNK/SPAK pathway to transporter regulation in AD remains largely unexplored (Barbour et al., 2024; Blum and Levi, 2024).